Beurs gesloten -
OTC Markets
19:00:22 08-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
290,8
USD
|
-2,09%
|
|
+0,27%
|
-22,04%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
12.508
|
23.546
|
37.429
|
24.078
|
20.462
|
17.222
|
-
|
-
|
Bedrijfswaarde
1 |
13.519
|
25.430
|
39.161
|
26.454
|
25.394
|
21.274
|
21.039
|
20.668
|
K/w-verhouding
|
83
x
|
104
x
|
127
x
|
37,2
x
|
111
x
|
73,3
x
|
51,1
x
|
39,9
x
|
Dividendrendement
|
0,37%
|
0,21%
|
0,21%
|
0,39%
|
0,22%
|
0,3%
|
0,41%
|
0,47%
|
Marktkapitalisatie/omzet
|
6,85
x
|
10,1
x
|
10,9
x
|
5,77
x
|
6,03
x
|
4,82
x
|
4,29
x
|
3,83
x
|
Bedrijfswaarde/omzet
|
7,4
x
|
10,9
x
|
11,4
x
|
6,34
x
|
7,48
x
|
5,95
x
|
5,24
x
|
4,6
x
|
Bedrijfswaarde/EBITDA
|
27,3
x
|
36,7
x
|
33,3
x
|
18,8
x
|
26,4
x
|
20
x
|
16,6
x
|
14
x
|
Bedrijfswaarde/FCF
|
89,2
x
|
93,7
x
|
85,4
x
|
125
x
|
86,4
x
|
66,4
x
|
44,5
x
|
33,2
x
|
FCF Yield
|
1,12%
|
1,07%
|
1,17%
|
0,8%
|
1,16%
|
1,51%
|
2,25%
|
3,02%
|
Price to Book
|
16,1
x
|
22,4
x
|
32,3
x
|
13,9
x
|
11
x
|
5,71
x
|
5,81
x
|
4,59
x
|
Aantal aandelen (in duizenden)
|
68.388
|
68.388
|
68.416
|
68.416
|
68.416
|
69.029
|
-
|
-
|
Referentieprijs
2 |
190,8
|
343,6
|
595,2
|
369,4
|
333,2
|
277,0
|
277,0
|
277,0
|
Datum van publicatie
|
28/01/20
|
27/01/21
|
27/01/22
|
26/01/23
|
26/01/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
1.827
|
2.336
|
3.449
|
4.175
|
3.396
|
3.573
|
4.016
|
4.491
|
EBITDA
1 |
495,8
|
692,2
|
1.175
|
1.410
|
962,7
|
1.064
|
1.265
|
1.474
|
Bedrijfsresultaat (EBIT)
1 |
398,3
|
456,1
|
903,2
|
1.065
|
503,9
|
691,1
|
880,7
|
1.056
|
Operationele Marge
|
21,8%
|
19,53%
|
26,18%
|
25,51%
|
14,84%
|
19,34%
|
21,93%
|
23,51%
|
Resultaat voor belastingen (EBT)
1 |
303,2
|
446,7
|
668,4
|
1.182
|
385,9
|
465,4
|
719,6
|
918,6
|
Nettowinst (verlies)
1 |
156,7
|
226,3
|
318,9
|
678,1
|
205,2
|
212,6
|
341,8
|
410,5
|
Nettomarge
|
8,58%
|
9,69%
|
9,25%
|
16,24%
|
6,04%
|
5,95%
|
8,51%
|
9,14%
|
WPA
2 |
2,300
|
3,310
|
4,670
|
9,920
|
3,000
|
3,779
|
5,421
|
6,950
|
Free Cash Flow
1 |
151,6
|
271,3
|
458,6
|
211,6
|
293,9
|
320,3
|
472,8
|
623,4
|
FCF-marge
|
8,3%
|
11,61%
|
13,3%
|
5,07%
|
8,66%
|
8,96%
|
11,77%
|
13,88%
|
Kasstroomconversie (ebitda)
|
30,58%
|
39,19%
|
39,03%
|
15%
|
30,53%
|
30,09%
|
37,37%
|
42,3%
|
Kasstroomconversie (nettowinst)
|
96,76%
|
119,89%
|
143,83%
|
31,2%
|
143,23%
|
150,67%
|
138,33%
|
151,87%
|
Dividend per aandeel
2 |
0,7100
|
0,7100
|
1,260
|
1,440
|
0,7400
|
0,8372
|
1,133
|
1,293
|
Datum van publicatie
|
28/01/20
|
27/01/21
|
27/01/22
|
26/01/23
|
26/01/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020 S1
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Omzet
1 |
1.057
|
922,3
|
1.025
|
1.036
|
2.060
|
1.053
|
1.062
|
903,2
|
831,8
|
810,7
|
849,8
|
819,6
|
844,7
|
904,2
|
961,8
|
-
|
-
|
EBITDA
1 |
293,5
|
308,6
|
349
|
348,5
|
697,5
|
354
|
358,9
|
271,9
|
245,1
|
216,7
|
229,3
|
234,4
|
231,4
|
261
|
293,9
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
214,4
|
230,6
|
278,7
|
276
|
-
|
272,4
|
237,6
|
178,5
|
125,4
|
80
|
120
|
122,3
|
156,5
|
186
|
217
|
-
|
-
|
Operationele Marge
|
20,29%
|
25%
|
27,2%
|
26,65%
|
-
|
25,88%
|
22,38%
|
19,76%
|
15,08%
|
9,87%
|
14,12%
|
14,92%
|
18,52%
|
20,57%
|
22,56%
|
-
|
-
|
Resultaat voor belastingen (EBT)
1 |
168
|
69,22
|
350,6
|
297,2
|
-
|
-
|
252
|
166,3
|
156,7
|
22
|
40,8
|
73,1
|
155,2
|
179,2
|
208,1
|
-
|
-
|
Nettowinst (verlies)
1 |
81,1
|
23,49
|
205,6
|
165,8
|
-
|
154,2
|
152,4
|
-
|
-
|
8,6
|
8,4
|
36,7
|
57,07
|
69,62
|
94
|
-
|
-
|
Nettomarge
|
7,67%
|
2,55%
|
20,06%
|
16,01%
|
-
|
14,65%
|
14,35%
|
-
|
-
|
1,06%
|
0,99%
|
4,48%
|
6,76%
|
7,7%
|
9,77%
|
-
|
-
|
WPA
2 |
1,190
|
0,3500
|
3,010
|
2,420
|
-
|
2,250
|
2,230
|
1,370
|
1,390
|
0,1300
|
0,1100
|
0,5400
|
0,8021
|
0,9860
|
1,315
|
-
|
-
|
Dividend per aandeel
2 |
-
|
1,260
|
-
|
-
|
-
|
-
|
1,440
|
-
|
1,440
|
-
|
0,7400
|
-
|
0,2370
|
0,2370
|
0,2370
|
0,2595
|
0,2595
|
Datum van publicatie
|
21/07/20
|
27/01/22
|
21/04/22
|
21/07/22
|
21/07/22
|
19/10/22
|
26/01/23
|
20/04/23
|
21/07/23
|
19/10/23
|
26/01/24
|
18/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
1.011
|
1.884
|
1.733
|
2.375
|
4.932
|
4.052
|
3.818
|
3.447
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
2,04
x
|
2,721
x
|
1,475
x
|
1,684
x
|
5,123
x
|
3,808
x
|
3,017
x
|
2,339
x
|
Free Cash Flow
1 |
152
|
271
|
459
|
212
|
294
|
320
|
473
|
623
|
ROE (netto-inkomsten/eigen vermogen)
|
27%
|
29,9%
|
48,3%
|
40,3%
|
16,7%
|
10,8%
|
12,7%
|
14,4%
|
ROA (netto-inkomsten/totale activa)
|
7,79%
|
5,98%
|
6,26%
|
10,3%
|
4,05%
|
2,41%
|
3,34%
|
4,34%
|
Totale activa
1 |
2.011
|
3.783
|
5.091
|
6.557
|
5.072
|
8.819
|
10.249
|
9.460
|
Nettoactief per aandeel
2 |
11,90
|
15,30
|
18,40
|
26,60
|
30,20
|
48,50
|
47,70
|
60,40
|
Cashflow per aandeel
2 |
5,520
|
7,480
|
25,30
|
10,70
|
12,50
|
12,00
|
13,60
|
14,70
|
Capex
1 |
226
|
240
|
407
|
523
|
560
|
454
|
449
|
434
|
Capex/omzet
|
12,35%
|
10,29%
|
11,8%
|
12,52%
|
16,48%
|
12,7%
|
11,18%
|
9,67%
|
Datum van publicatie
|
28/01/20
|
27/01/21
|
27/01/22
|
26/01/23
|
26/01/24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
277
EUR Gemiddelde koersdoel
329,2
EUR Spread / Gemiddelde doel +18,86% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -42,09% | 2,85 mld. | | +23,15% | 1,95 mld. | | +3,08% | 1,72 mld. | | +28,27% | 1,26 mld. | | -11,16% | 1,02 mld. | | -17,21% | 950 mln. | | +0,07% | 777 mln. | | -23,17% | 643 mln. | | +11,79% | 518 mln. |
Medisch diagnose- & testmateriaal
|